MetLife Investment Management, LLC - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 127 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$592,284
+3.1%
28,9060.0%0.01%
+25.0%
Q2 2023$574,362
+19.0%
28,906
+2.6%
0.00%0.0%
Q1 2023$482,826
-12.5%
28,1860.0%0.00%0.0%
Q4 2022$551,600
+50.4%
28,186
+22.7%
0.00%
+33.3%
Q3 2022$366,681
+16.0%
22,9750.0%0.00%0.0%
Q2 2022$316,136
-13.2%
22,9750.0%0.00%
+50.0%
Q1 2022$364,384
+13.8%
22,975
+56.6%
0.00%
-33.3%
Q4 2021$320,333
-27.0%
14,6740.0%0.00%
-25.0%
Q3 2021$438,606
-32.5%
14,6740.0%0.00%
-33.3%
Q2 2021$649,911
-0.2%
14,6740.0%0.01%0.0%
Q1 2021$651,085
-19.1%
14,6740.0%0.01%
-25.0%
Q4 2020$804,722
+139.9%
14,6740.0%0.01%
+100.0%
Q3 2020$335,448
+9.2%
14,6740.0%0.00%
+33.3%
Q2 2020$307,127
+50.0%
14,6740.0%0.00%0.0%
Q1 2020$204,702
-38.7%
14,6740.0%0.00%0.0%
Q4 2019$333,980
+95.4%
14,6740.0%0.00%
+50.0%
Q3 2019$170,952
-22.3%
14,6740.0%0.00%0.0%
Q2 2019$220,109
+19.7%
14,674
+40.0%
0.00%0.0%
Q1 2019$183,854
+18.4%
10,4820.0%0.00%0.0%
Q4 2018$155,343
-39.8%
10,4820.0%0.00%
-33.3%
Q3 2018$258,06710,4820.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
M28 Capital Management LP 665,880$10,627,00011.09%
RTW INVESTMENTS, LP 15,802,802$252,213,0005.82%
Ally Bridge Group (NY) LLC 479,506$7,653,0005.05%
TANG CAPITAL MANAGEMENT LLC 1,265,900$20,204,0002.48%
TIGER MANAGEMENT L.L.C. 279,700$4,464,0001.95%
Prosight Management, LP 200,000$3,192,0001.71%
COWEN AND COMPANY, LLC 999,588$15,953,0001.53%
Boxer Capital, LLC 1,466,051$23,398,0001.32%
Affinity Asset Advisors, LLC 267,794$4,274,0001.19%
HARBOR CAPITAL ADVISORS, INC. 66,410$1,060,0000.97%
View complete list of ROCKET PHARMACEUTICALS INC shareholders